"Medibio Limited is pleased to announce that it has received firm commitments to raise approximatley $3.1 million by the placement of 7,730,087 ordinary shares at a price of $0.40.
The placement was strongly supported by domestic instituitions, Foster Stockbroking has acted as sole Lead Manager for the capital raising.
The company intends to use the the placement proceeds to fast track the commercialisation of its Circadian Heart Rate (CHR) technology.
A number of initatives will be moved forward with the aim to start them this calendar year rather than their previously programmed starts in
2016 or 2017."
Overall, a positive. Fast tracking and underwritten by Fosters.
"Medibio Limited is pleased to announce that it has received...
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
